Podcast: Conversations around interchangeability and biosimilar entries in new therapeutic categories

By AmerisourceBergen

Launches in ophthalmology and the first interchangeable insulin biosimilar in the U.S.  bring new opportunities for this exciting product class. Listen in as our experts discuss these developments. 

You can also listen and subscribe wherever you get your podcasts, like Apple or Spotify.

Continue the conversation

Learn more about our solutions for this important product category.